Treatment of SARS-CoV-2: How far have we reached?

Waquar Ahsan; Shamama Javed; Mohammed Al Bratty; Hassan A. Alhazmi; Asim Najmi

doi:10.5582/ddt.2020.03008

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Treatment of SARS-CoV-2: How far have we reached?

Waquar Ahsan, Shamama Javed, Mohammed Al Bratty, Hassan A. Alhazmi, Asim Najmi

著者情報

キーワード: SARS-CoV-2, pandemic, antiviral, corona virus, clinical trial

ジャーナルフリー早期公開

論文ID: 2020.03008

DOI https://doi.org/10.5582/ddt.2020.03008

この記事には本公開記事があります。

The final version of this article is now available: Vol. 14 (2020), No. 2 pp. 67-72

詳細

抄録

The virus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries and territories worldwide. It has been declared as pandemic by World Health Organization (WHO) and the whole world is suffering from corona virus disease 2019 (COVID-19). Currently, no treatment for SARS-CoV-2 are approved because of lack of evidence, but a number of clinical trials are in process and we are expecting fruitful results very soon. This review focuses on various approaches of treatment and few of the most recent clinical trials carried out in this field.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）